Airxpanders (PRIVATE.ARXXL)

Overall impact
B (76)

Commentary

Airxpanders is a strong overall performer. With a 'B' rating of 76.2 for overall impact (90th percentile compared to all companies), Airxpanders ranks 20th out of 155 industry peers, behind Edap Tms, Helius Medical Technologies, Non Invasive Monitoring Systems and 16 others, and ahead of Hologic, American Shared Hospital Services, Accuray and 132 others. On top material causes for Airxpanders's industry (Healthcare Equipment), Airxpanders performs well in Child and Maternal Health (86.8 score), Racial Justice and Civil Rights (95.2), Accountable Institutions (88.3) and 5 other causes where it received an 'A' score and performs poorly in Disease Eradication (39.6 score).
Impact
Cause PRIVATE.ARXXL
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
2005
Employees
70
Sector
Health Care
Industry
Health Care Equipment & Supplies
Sub-industry
Health Care Equipment
SASB industry
Medical Equipment & Supplies
Headquarters
California, United States
Share classes
PRIVATE.ARXXL
Description
Developer of medical technology designed for breast tissue expansion after reconstructive surgery. The company operates as a medical device company engaged in designing, manufacturing, selling, and distributing tissue expanders for breast reconstruction procedures following mastectomy.
Material causes
Ethos considers the following causes material for Airxpanders, based on its industry sub-industry Health Care Equipment. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.